Clinical TrialsSearch results
Number of results: 734
Completed
- A PHASE III OPEN-LABEL EXTENSION STUDY TO EVALUATE LONG-TERM SAFETY AND EFFICACY OF PRM-151(rhPTX-2) IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS (IPF)
- Idiopathic pulmonary fibrosis
- Shimoda Yukiko
- 2021-12-26
Completed
- A Phase 2 Study to Evaluate Dose-Response of TAS-115 in Patients with Chronic Fibrosing Interstitial Lung Diseases with a Progressive Phenotype
- Chronic Fibrosing Interstitial Lung Diseases with a Progressive Phenotype
- Motoo Yoshiharu
- 2021-07-12
Completed
- A multicenter extension study of empagliflozin in patients with refractory diabetes mellitus with insulin resistance
- Insulin resistance syndrome (type A, type B, type non-A non-B), Lipoatrophic diabetes mellitus
- Ogawa Wataru
- 2020-01-15
Completed
- A multi-center study of empagliflozin in patients with refractory diabetes mellitus with insulin resistance
- Insulin resistance syndrome (type A, type B, type non-A non-B), Lipoatrophic diabetes mellitus
- Ogawa Wataru
- 2019-06-26
No Longer Recruiting
- Phase II study of high-dose thoracic 3D-conformal radiotherapy without elective nodal irradiation concurrently combined with cisplatin and vinorelbine chemotherapy in patients with inoperable stage III non-small cell lung cancer
- inoperable stage III non-small cell lung cancer
- National Cancer Center Hospital
- 2009-03-02
No Longer Recruiting
- Feasibility trial of UFT after withdrawal of adjuvant TS-1 with adverse effects in patients with curatively resected gastric cancer.
- Gastric Cancer
- Division of Gastrointestinal Surgery, Kobe University Hospital
- 2008-05-07
No Longer Recruiting
- A Randomized Controlled Trial of the Preventive Effect of Haptoglobin Administration on Hemolysis-Related Organ Damage in Patients undergoing Cardiovascular Surgery
- Valvular heart disease,aortic aneurysm,aortic dissection,coronary artery disease
- Hokka Mai
- 2022-01-05
No Longer Recruiting
- A Phase 3, Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of Pamrevlumab in Subjects with Idiopathic Pulmonary Fibrosis (IPF)
- Idiopathic Pulmonary Fibrosis
- Ewa Carrier
- 2022-02-05
No Longer Recruiting
- A double-blind, placebo-controlled, randomized, dose-escalating, multicenter, Phase 1 study to assess the safety and tolerability of ART-123 in combination with leucovorin/5-fluorouracil/oxaliplatin and bevacizumab in metastatic colorectal cancer patients
- metastatic colorectal cancer
- Tawara Shunsuke
- 2022-02-01
Recruiting
- Window trial
- Solid tumor
- Tsubamoto Hiroshi
- 2019-04-16